Feiyan Lin
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Redox biology and oxidative stress
Papers in
-
- Metabolomics and Mass Spectrometry Studies 5
- S100 Proteins and Annexins 4
- Surgery 10
- Paraquat toxicity studies and treatments 6
- Co-authors
- Hongcui Cao (12 shared papers)Lei Jiang (8 shared papers)Jiong Yu (9 shared papers)Lufeng Hu (14 shared papers)Qiaoling Pan (7 shared papers)Lanjuan Li (6 shared papers)Xiaowei Shi (6 shared papers)Jiahang Zhou (5 shared papers)
- Journals
- Pharmacology (3 papers)Lipids in Health and Disease (2 papers)Journal of Chromatography B (2 papers)Chemical Research in Toxicology (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Feiyan Lin
40 papers receiving 827 citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 231
- Molecular Biology 500
- Hepatology 45
- Genetics 55
- Immunology 79
Countries citing papers authored by Feiyan Lin
This map shows the geographic impact of Feiyan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiyan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiyan Lin more than expected).
Fields of papers citing papers by Feiyan Lin
This network shows the impact of papers produced by Feiyan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiyan Lin. The network helps show where Feiyan Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Feiyan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury Hit paper breakdown → | 2022 | 147 |
| 2 | 2021 | 67 | |
| 3 | 2022 | 54 | |
| 4 | 2017 | 44 | |
| 5 | 2017 | 44 | |
| 6 | 2015 | 41 | |
| 7 | 2021 | 40 | |
| 8 | 2019 | 36 | |
| 9 | 2024 | 30 | |
| 10 | 2013 | 30 | |
| 11 | 2020 | 28 | |
| 12 | 2014 | 27 | |
| 13 | 2021 | 26 | |
| 14 | 2016 | 26 | |
| 15 | 2018 | 24 | |
| 16 | Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide. | 2014 | 23 |
| 17 | 2019 | 18 | |
| 18 | 2017 | 17 | |
| 19 | 2019 | 11 | |
| 20 | Application of back-propagation artificial neural network and curve estimation in pharmacokinetics of losartan in rabbit. | 2015 | 11 |
About Feiyan Lin
Feiyan Lin is a scholar working on Molecular Biology, Surgery, Epidemiology, Hepatology and Cancer Research, having authored 41 papers that have together received 839 indexed citations. Recurring topics across this work include Paraquat toxicity studies and treatments (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Liver Disease Diagnosis and Treatment (5 papers), S100 Proteins and Annexins (4 papers), Traditional Chinese Medicine Analysis (4 papers), MicroRNA in disease regulation (4 papers), Mesenchymal stem cell research (3 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Cancer Research (231 citations), Molecular Biology (500 citations), Hepatology (45 citations), Genetics (55 citations) and Immunology (79 citations). Feiyan Lin has collaborated with scholars based in China and United States. Frequent co-authors include Hongcui Cao, Lei Jiang, Jiong Yu, Lufeng Hu, Qiaoling Pan, Lanjuan Li, Xiaowei Shi, Jiahang Zhou, Bing Feng and Jiaqi Zhu. Their work appears in journals such as Pharmacology, Lipids in Health and Disease, Journal of Chromatography B, Chemical Research in Toxicology and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.